Advertisement

Topics

Search Results for "Biliary Dyskinesia Mayo Clinic"

05:59 EDT 24th May 2017 | BioPortfolio

Matching Channels

Biliary excretion

Acalculous Biliary Pain

Primary Biliary Cirrhosis PBC

Testing for Hepatic and Biliary Disorders

Gaucher's disease

Gaucher's (go-SHAYZ) disease occurs when certain harmful fatty substances accumulate to excessive levels in your liver, spleen, lungs, bone marrow and, less commonly, brain. This accumulation of...

Matching News

BioSig Technologies, Mayo Clinic partners

BioSig Technologies, a medical device company developing the PURE EP System, a proprietary platform designed to address an unmet technology need for the $4 billion electrophysiology (EP) marketplace, ...

BioSig Technologies, Mayo Clinic partner

BioSig Technologies, a medical device company developing the PURE EP System, a proprietary platform designed to address an unmet technology need for the $4 billion electrophysiology (EP) marketplace, ...

Mayo Clinic researchers clarify chemo resistance, and perhaps a new therapy

(Mayo Clinic) Mayo Clinic scientists have identified a specific protein implicated in drug resistance, as well as a possible therapeutic tool. Their work appears in the EMBO Journal.

Mayo Clinic researchers demonstrate value of second opinions

(Mayo Clinic) Many patients come to Mayo Clinic for a second opinion or diagnosis confirmation before treatment for a complex condition. In a new study, Mayo Clinic reports that as many as 88 percent ...

Medical Device Company BioSig Lands 10-Year with Strategic Partnership with Mayo Clinic

Medical device company BioSig has inked a 10-year strategic partnership with Mayo Clinic and Mayo Clinic Ventures. The expanded par expanded collaboration with Mayo builds upon the work realized under...

Mayo Clinic researchers identify therapy

(Mayo Clinic) Mayo Clinic researchers have found that an experimental drug, LCL161, stimulates the immune system, leading to tumor shrinkage in patients affected by multiple myeloma. The findings are ...

Mayo Clinic researchers uncover new agents

(Mayo Clinic) Mayo Clinic researchers have uncovered three new agents to add to the emerging repertoire of drugs that aim to delay the onset of aging by targeting senescent cells -- cells that contrib...

Post-Op complications measurements differ, Mayo Clinic study finds

(Mayo Clinic) How do medical professionals determine whether or not a patient has experienced a post-operative complication? A team of Mayo Clinic physicians and researchers has published results of a...

Matching PubMed Articles

Melanoma Screening: Thinking Beyond the Guidelines.

Gender Differences in Medicine-From Medical School to Medicare.

How Efficient Is Subthalamic Deep Brain Stimulation in Reducing Dyskinesia in Parkinson's Disease?

Dyskinesia is among the most troublesome symptoms of advanced Parkinson's disease (PD). The recently developed Unified Dyskinesia Rating Scale (UDysRS) can simultaneously measure several subjective an...

MicroRNA-155 modulates bile duct inflammation via targeting suppressor of cytokine signaling 1 in biliary atresia.

Biliary atresia (BA) is an etiologically perplexing disease, manifested by neonatal cholestasis, repeated cholangitis, and progressive biliary fibrosis. MiR-155 has been implicated to modulate the imm...

Epigastric symptoms of gallbladder dyskinesia mistaken for functional dyspepsia: Retrospective observational study.

Functional dyspepsia (FD) is a constellation of epigastric symptoms originating in the gastroduodenal region without organic and metabolic cause. However, similar confounding symptoms can also appear ...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement